troglitazone has been researched along with epidermal growth factor in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansson, A; Hehenberger, K | 1 |
Hiraoka, S; Kitamura, S; Kiyohara, T; Matsuzawa, Y; Miyazaki, Y; Nagasawa, Y; Shinomura, Y; Takakura, R; Toyota, M | 1 |
Diggle, C; Holder, J; Lee, WC; Selby, PJ; Southgate, J; Stahlschmidt, J; Trejdosiewicz, LK; Varley, CL | 1 |
Haldosén, LA; Olsen, H | 1 |
Li, F; Shi, J; Song, J; Wang, D; Zhou, Y | 1 |
Friday, E; Oliver, R; Turturro, F; Welbourne, T | 1 |
Chin, LH; Hsu, SP; Liang, YC; Zhong, WB | 1 |
7 other study(ies) available for troglitazone and epidermal growth factor
Article | Year |
---|---|
High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors.
Topics: Antioxidants; Cell Division; Cells, Cultured; Chromans; Diabetes Mellitus; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Epidermal Cells; Epidermal Growth Factor; Fibroblasts; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin-Like Growth Factor I; Protein Kinase C; Protein Tyrosine Phosphatases; Thiazoles; Thiazolidinediones; Troglitazone; Wound Healing | 1997 |
PPARgamma agonists inhibit cell growth and suppress the expression of cyclin D1 and EGF-like growth factors in ras-transformed rat intestinal epithelial cells.
Topics: Animals; Blotting, Northern; Blotting, Western; Cell Division; Cell Line; Cell Line, Transformed; Cell Nucleus; Chromans; Cyclin D1; DNA, Complementary; Dose-Response Relationship, Drug; Epidermal Growth Factor; Epithelial Cells; Flow Cytometry; Humans; Hypoglycemic Agents; Intestines; Ligands; Luciferases; Plasmids; Promoter Regions, Genetic; ras Proteins; Rats; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Rosiglitazone; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Troglitazone | 2001 |
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Topics: Active Transport, Cell Nucleus; Adipocytes; Anilides; Animals; Blotting, Western; Cattle; Cell Differentiation; Cell Line; Cell Proliferation; Chromans; Enzyme Inhibitors; Epidermal Growth Factor; Epithelium; ErbB Receptors; Gene Expression Regulation; Humans; Immunoprecipitation; Ligands; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Quinazolines; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Time Factors; Troglitazone; Uroplakin Ia; Uroplakin Ib; Uroplakin II; Uroplakin III; Urothelium | 2004 |
Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
Topics: 5' Flanking Region; Animals; Cell Line; Chromans; Enzyme Inhibitors; Epidermal Growth Factor; Epithelial Cells; Fibrinolytic Agents; Gene Expression Regulation; Genes, Reporter; Ligands; Luciferases; Mammary Glands, Animal; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; PPAR gamma; Regulatory Elements, Transcriptional; Repressor Proteins; STAT5 Transcription Factor; Thiazolidinediones; Troglitazone; Up-Regulation | 2006 |
Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation.
Topics: 3T3-L1 Cells; Acetophenones; Adipocytes; Adipogenesis; Animals; Benzopyrans; Carbazoles; Cell Differentiation; Cell Membrane; Cell Proliferation; Chromans; Cytosol; Epidermal Growth Factor; Gene Expression; Genes, Dominant; Indoles; Mice; Mutant Proteins; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Protein Transport; Tetradecanoylphorbol Acetate; Thiazolidinediones; Transforming Growth Factor beta; Troglitazone | 2006 |
Role of epidermal growth factor receptor (EGFR)-signaling versus cellular acidosis via Na+/H+ exchanger1(NHE1)-inhibition in troglitazone-induced growth arrest of breast cancer-derived cells MCF-7.
Topics: Acidosis; Breast Neoplasms; Cation Transport Proteins; Cell Line, Tumor; Cell Proliferation; Chromans; DNA, Neoplasm; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Phosphoproteins; Signal Transduction; Sodium-Hydrogen Exchanger 1; Sodium-Hydrogen Exchangers; Thiazolidinediones; Transcriptional Activation; Troglitazone | 2007 |
Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
Topics: Cell Line, Tumor; Cell Movement; Chromans; Cyclic AMP Response Element-Binding Protein; Cysteine-Rich Protein 61; Down-Regulation; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Humans; Lovastatin; Signal Transduction; Thiazolidinediones; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Troglitazone | 2015 |